CF
GILD icon

Covea Finance’s Gilead Sciences GILD Stock Holding History

Covea Finance’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.8M Buy
196,020
+117,220
+149% +$15.4M 0.78% 40
2026
Q1 		$11M Buy
+78,800
New +$11M 0.38% 74
2025
Q4 		– Sell
-51,700
Closed -$5.74M – 129
2025
Q3 		$5.74M Hold
51,700
– – 0.2% 95
2025
Q2 		$5.73M Buy
51,700
+21,200
+70% +$2.26M 0.21% 90
2025
Q1 		$3.42M Buy
+30,500
New +$3.15M 0.16% 91

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Covea Finance's GILD Position: Q2 2026 in Review

Covea Finance increased its Gilead Sciences (GILD) stake by 149% in Q2 2026, buying an estimated $15.4M and bringing the position to 196,020 shares worth $24.8M. The position accounts for 0.78% of the portfolio, ranked #40.

Covea Finance first reported a position in GILD in Q1 2025 and has held it in 5 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Covea Finance held 196,020 shares of Gilead Sciences worth $24.8M as of Q2 2026.
  • Covea Finance bought 117,220 Gilead Sciences shares in Q2 2026, an estimated $15.4M.
  • Gilead Sciences made up 0.78% of Covea Finance's portfolio in Q2 2026, its #40 holding.
  • Covea Finance first reported a position in Gilead Sciences in Q1 2025 and has held it in 5 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Covea Finance's 13F filing for Q2 2026, filed 13 Jul 2026.